CN102060855B - 一种八氢-吡喏-并[3,4-c]吡啶-衍生物的制备方法 - Google Patents
一种八氢-吡喏-并[3,4-c]吡啶-衍生物的制备方法 Download PDFInfo
- Publication number
- CN102060855B CN102060855B CN200910201787.7A CN200910201787A CN102060855B CN 102060855 B CN102060855 B CN 102060855B CN 200910201787 A CN200910201787 A CN 200910201787A CN 102060855 B CN102060855 B CN 102060855B
- Authority
- CN
- China
- Prior art keywords
- pyridine
- pyrrole
- octahydro
- hydrogen
- dicarbapentaborane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 *N(C1)CC2C1CCN(Cc1ccccc1)C2 Chemical compound *N(C1)CC2C1CCN(Cc1ccccc1)C2 0.000 description 1
- DUZSGEYBDJCPRP-UHFFFAOYSA-N C(c1ccccc1)N1CC(CNC2)C2CC1 Chemical compound C(c1ccccc1)N1CC(CNC2)C2CC1 DUZSGEYBDJCPRP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910201787.7A CN102060855B (zh) | 2009-11-12 | 2009-11-12 | 一种八氢-吡喏-并[3,4-c]吡啶-衍生物的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910201787.7A CN102060855B (zh) | 2009-11-12 | 2009-11-12 | 一种八氢-吡喏-并[3,4-c]吡啶-衍生物的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102060855A CN102060855A (zh) | 2011-05-18 |
CN102060855B true CN102060855B (zh) | 2014-04-16 |
Family
ID=43996376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910201787.7A Active CN102060855B (zh) | 2009-11-12 | 2009-11-12 | 一种八氢-吡喏-并[3,4-c]吡啶-衍生物的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102060855B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998058947A1 (en) * | 1997-06-25 | 1998-12-30 | Pfizer Inc. | Dipeptide derivatives as growth hormone secretagogues |
WO2005103003A2 (en) * | 2004-04-26 | 2005-11-03 | Pfizer Inc. | Pyrrolopyridine derivatives and their use as hiv-integrase inhibitors |
-
2009
- 2009-11-12 CN CN200910201787.7A patent/CN102060855B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998058947A1 (en) * | 1997-06-25 | 1998-12-30 | Pfizer Inc. | Dipeptide derivatives as growth hormone secretagogues |
WO2005103003A2 (en) * | 2004-04-26 | 2005-11-03 | Pfizer Inc. | Pyrrolopyridine derivatives and their use as hiv-integrase inhibitors |
Also Published As
Publication number | Publication date |
---|---|
CN102060855A (zh) | 2011-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2011205891B2 (en) | Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same | |
CN106365986B (zh) | 化合物及其制备方法和在合成布瓦西坦中的用途 | |
US20040106818A1 (en) | Process for the preparation of cyclohexanol derivatives | |
CN105330598A (zh) | 一种吡非尼酮的制备方法 | |
CN107337634A (zh) | 一种阿贝西利中间体化合物的制备方法 | |
CN101654419A (zh) | 马来酸氟伏沙明的制备方法 | |
CN108218798B (zh) | Apabetalone的制备方法 | |
CN103896795B (zh) | 甲酰胺化合物、其中间体的制备方法及其用途 | |
CN102964346A (zh) | 一种制备(S,S)-八氢-6H-吡咯并[3,4-b]吡啶的方法 | |
CN104817583B (zh) | 碳桥联双酰胺基稀土胺化物及其制备和在催化醛与胺酰胺化合成反应中的应用 | |
CN102060855B (zh) | 一种八氢-吡喏-并[3,4-c]吡啶-衍生物的制备方法 | |
CN105358529A (zh) | 一种合成阿哌沙班重要中间体的新方法 | |
CN114751852B (zh) | 一种西咯多辛关键中间体的制备方法 | |
CN106748966A (zh) | 一种雷米普利关键中间体的合成方法 | |
CN106111190A (zh) | 一种手性联芳骨架吡哆胺类催化剂及其合成方法与应用 | |
CN103787968B (zh) | 化合物的制备方法 | |
CN112812033B (zh) | 一种奥司他韦的新合成方法 | |
CN104592122A (zh) | 3-(4-甲基-1h-咪唑-1-基)-5-(三氟甲基)苯胺的制备方法 | |
KR100574350B1 (ko) | 2-아미노피리딘 유도체의 제조방법 | |
CN104557678A (zh) | 一种制备阿雷地平的方法 | |
CN102531954B (zh) | 一种芳香偶氮化合物的合成方法 | |
CN112521289B (zh) | 一种氧杂烯丙基胺类化合物及其制备方法和应用 | |
CN104860881A (zh) | 8-(硝基甲基)喹啉类化合物和8-甲氨基四氢喹啉类化合物的合成方法 | |
CN105001200A (zh) | 一种抗血管新生化合物及其中间体的制备方法 | |
CN115260094B (zh) | 一种新的盐酸去甲乌药碱的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: TIANJIN YAOMING KANGDE NEW MEDICINE DEVELOPMENT CO., LTD. Effective date: 20141029 Owner name: WUHAN YAOMING KANGDE NEW DRUGS DEVELOPMENT CO., LT Free format text: FORMER OWNER: SHANGHAI YAOMING KANGDE NEW MEDICINE DEVELOPMENT CO., LTD. Effective date: 20141029 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200131 PUDONG NEW AREA, SHANGHAI TO: 430079 WUHAN, HUBEI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141029 Address after: 430079 Wuhan Province, East Lake City Development Zone, high tech Avenue, No. 666, No. Patentee after: Wuhan AppTec New Drug Development Co., Ltd. Address before: 200131 Shanghai City, Pudong New Area Waigaoqiao Free Trade Zone Foote Road No. 288 Patentee before: Shanghai Yaoming Kangde New Medicine Development Co., Ltd. Patentee before: Tianjin Yaoming Kangde New Medicine Development Co., Ltd. |